Pages that link to "Q34985014"

The following pages link to Testosterone therapy in HIV wasting syndrome: systematic review and meta-analysis (Q34985014):

Displaying 25 items.

• THERAPY OF ENDOCRINE DISEASE: Testosterone supplementation and body composition: results from a meta-analysis study (Q26780084) (← links)
• Effects of a supraphysiological dose of testosterone on physical function, muscle performance, mood, and fatigue in men with HIV-associated weight loss (Q33330243) (← links)
• New insights into the role of anabolic interventions in dialysis patients with protein energy wasting (Q33935889) (← links)
• Understanding and managing cancer cachexia (Q33966821) (← links)
• Testosterone therapy and cardiovascular events among men: a systematic review and meta-analysis of placebo-controlled randomized trials. (Q34676945) (← links)
• Role of testosterone in maintaining lean body mass and bone density in HIV-infected patients (Q35204837) (← links)
• "Non-thyroidal illness syndrome" is functional central hypothyroidism, and if severe, hormone replacement is appropriate in light of present knowledge (Q35727716) (← links)
• Topical testosterone treatment for chronic allograft failure in liver transplant recipients with recurrent hepatitis C virus (Q36027433) (← links)
• Drug insight: Testosterone and selective androgen receptor modulators as anabolic therapies for chronic illness and aging (Q36130944) (← links)
• National Athletic Trainers' Association position statement: anabolic-androgenic steroids (Q36299949) (← links)
• Aging and HIV infection (Q36482458) (← links)
• Counteracting muscle wasting in HIV-infected individuals. (Q36582724) (← links)
• The molecular mechanisms of skeletal muscle wasting: implications for therapy. (Q36607060) (← links)
• Anabolic steroids: dependence and complications of chronic use. (Q37495640) (← links)
• Hypogonadism in human immunodeficiency virus-positive men. (Q37500129) (← links)
• Testosterone and obesity (Q38485746) (← links)
• ASHP Guidelines on Pharmacist Involvement in HIV Care (Q38739944) (← links)
• Optimal diagnostic measures and thresholds for hypogonadism in men with HIV/AIDS: comparison between 2 transdermal testosterone replacement therapy gels (Q42286790) (← links)
• Testosterone replacement therapy in men with hypogonadism and HIV/AIDS: results from the TRiUS registry (Q42286793) (← links)
• Self-reported psychological distress associated with steroid therapy for HIV (Q42752404) (← links)
• HIV and testosterone therapy (Q44392677) (← links)
• Concerning "Effects of a supraphysiological dose of testosterone on physical function, fatigue, and mood in men with human immunodeficiency virus-associated weight loss". (Q45390275) (← links)
• Effects of nandrolone decanoate compared with placebo or testosterone on HIV-associated wasting (Q46957628) (← links)
• Hypogonadism in the HIV-Infected Man. (Q54101646) (← links)
• Effects of Testosterone Supplementation on Body Composition in HIV Patients: A Meta-analysis of Double-blinded Randomized Controlled Trials (Q90734113) (← links)